A report released today by Jefferies & Co about Nu Skin Enterprises (NYSE:NUS) raises the target price to $61.00
- Updated: September 22, 2016
Nu Skin Enterprises (NYSE:NUS) had its target price raised to $61.00 by Jefferies & Co in a report released 09/22/2016. The new target price indicates a possible downside of -0.04% based on the company's last stock close price.
Previously on 9/21/2016, Citigroup reported about Nu Skin Enterprises (NYSE:NUS) raised the target price from $66.00 to $69.00. At the time, this indicated a possible upside of 0.17%.
Just yesterday Nu Skin Enterprises (NYSE:NUS) traded 2.92% higher at $63.79. Nu Skin Enterprises’s 50-day moving average is $58.46 and its 200-day moving average is $45.95. The last stock price is up 39.51% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 214,417 shares of NUS traded hands, down from an average trading volume of 702,322
Recent Performance Chart
Nu Skin Enterprises has 52 week low of $23.51 and a 52 week high of $64.10 with a PE ratio of 36.78 and has a market capitalization of $0.
In addition to Jefferies & Co reporting its stock price target, a total of 8 brokerages have issued a ratings update on the company. The average stock price target is $41.50 with 3 brokerages rating the stock a strong buy, 1 brokerage rating the stock a buy, 3 brokerages rating the stock a hold, 1 brokerage rating the stock a underperform, and finally 1 brokerage rating the stock a sell.
Brief Synopsis On Nu Skin Enterprises (NYSE:NUS)
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum. The Pharmanex product line includes ageLOC TR90 weight management and body shaping system, and LifePak and ageLOC R2 nutritional supplements. The Company has operations in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). It is focused on offering ageLOC Youth nutritional supplement and ageLOC Me personalized skin care system. The Company also offers household products and technology services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.